Abaasa, A.; Mayanja, Y.; Anywaine, Z.; Kusemererwa, S.; Ruzagira, E.; Kaleebu, P.
Counterfactual Groups to Assess Vaccine or Treatment Efficacy in HIV Prevention Trials in High-Risk Populations in Uganda. Vaccines 2025, 13, 844.
https://doi.org/10.3390/vaccines13080844
AMA Style
Abaasa A, Mayanja Y, Anywaine Z, Kusemererwa S, Ruzagira E, Kaleebu P.
Counterfactual Groups to Assess Vaccine or Treatment Efficacy in HIV Prevention Trials in High-Risk Populations in Uganda. Vaccines. 2025; 13(8):844.
https://doi.org/10.3390/vaccines13080844
Chicago/Turabian Style
Abaasa, Andrew, Yunia Mayanja, Zacchaeus Anywaine, Sylvia Kusemererwa, Eugene Ruzagira, and Pontiano Kaleebu.
2025. "Counterfactual Groups to Assess Vaccine or Treatment Efficacy in HIV Prevention Trials in High-Risk Populations in Uganda" Vaccines 13, no. 8: 844.
https://doi.org/10.3390/vaccines13080844
APA Style
Abaasa, A., Mayanja, Y., Anywaine, Z., Kusemererwa, S., Ruzagira, E., & Kaleebu, P.
(2025). Counterfactual Groups to Assess Vaccine or Treatment Efficacy in HIV Prevention Trials in High-Risk Populations in Uganda. Vaccines, 13(8), 844.
https://doi.org/10.3390/vaccines13080844